Inist ST Co., Ltd.

Since 2000, INIST ST has headed developing raw material medicine and its synthesis technology. Based on change and innovation, and love for life, INIST ST has researched and developed excellent-quality generic raw materials and new salt IMDs (incrementally modified drug) starting from cerebrovascular medicine and has supplied them domestically and overseas. 
INIST’s products show high demand for generic APIs in domestic market, yet overseas sales is also steadily increasing. Now, we are aiming to expand overseas sales, targeting USA, Europe, Middle East, etc.